Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

Inhibitors of Gram-positive Cell Wall Synthesis

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...

Inhibitors of Bacterial DNA Synthesis

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...

Antibiotic Selection

Antibiotic Selection

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Antimicrobial Proteins

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Plasma and intrapulmonary pharmacokinetics of ceftibuten and ledaborbactam in healthy male and female adults.

Antimicrobial agents and chemotherapy·2026

Same author

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning.

Pharmacotherapy·2026

Same author

Pharmacokinetic drug evaluation of co-packaged sulbactam for injection and durlobactam for injection for the treatment of <i>Acinetobacter baumannii-calcoaceticus</i> complex in HABP/VABP.

Expert opinion on drug metabolism & toxicology·2025

Same author

Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Same author

Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participants.

Antimicrobial agents and chemotherapy·2025

Same author

Risk of rehospitalization due to <i>Clostridioides difficile</i> infection among hospitalized patients with <i>Clostridioides difficile</i>: a cohort study.

Infection control and hospital epidemiology·2024

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Tigecycline: a novel broad-spectrum antimicrobial.

Christine M Slover¹, Keith A Rodvold, Larry H Danziger

¹Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL 60612, USA.

The Annals of Pharmacotherapy

|May 24, 2007

Summary

Tigecycline is an effective antibiotic for complicated skin and skin structure infections (cSSSI) and complicated intra-abdominal infections (cIAI). While it shows broad-spectrum activity against resistant bacteria, its use in critically ill patients requires further study.

More Related Videos

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Related Experiment Videos

Last Updated: Jul 14, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Area of Science:

Pharmacology and Microbiology
Infectious Diseases
Drug Efficacy and Safety

Background:

Tigecycline represents a novel glycylcycline antibiotic.
The emergence of multidrug-resistant bacteria necessitates new therapeutic options.

Purpose of the Study:

To conduct a literature review on the antibiotic tigecycline.
To evaluate the safety and efficacy of tigecycline for specific infections.

Main Methods:

Literature search of MEDLINE and International Pharmaceutical Abstracts.
Inclusion of in vitro, clinical, and pharmacokinetic studies.
Analysis of clinical trial data for complicated skin and skin structure infections (cSSSI) and complicated intra-abdominal infections (cIAI).

Main Results:

Tigecycline demonstrated comparable efficacy to comparator antibiotics in treating cSSSI and cIAI.
Exhibited broad-spectrum activity against resistant pathogens like MRSA and ESBL-producing Enterobacteriaceae.
Adverse effects were primarily nausea and vomiting; inadequate activity against Pseudomonas spp. was noted.

Conclusions:

Tigecycline is approved for cSSSI and cIAI, with limited reported resistance to date.
Caution is advised for use in critically ill patients pending further research.
Potential for resistance development with widespread tigecycline use is anticipated.